High serum testosterone concentrations in a diabetic woman with end-stage renal disease

2013 ◽  
Vol 60 (9) ◽  
pp. e23-e25
Author(s):  
María Rosario Vallejo Mora ◽  
Raquel Yahyaoui ◽  
Anita Dayaldasani ◽  
Óscar Pozo ◽  
Stella González Romero
1980 ◽  
Vol 14 (7-8) ◽  
pp. 493-497
Author(s):  
Mike K. Mirahmadi ◽  
Nick D. Vaziri

Androgen compounds are commonly used in the treatment of anemia in patients with end-stage renal disease. The two widely used androgen compounds, nandrolone decanoate (ND) and testosterone enanthate (TE), have been reported to improve anemia in this setting. We conducted a controlled crossover study to evaluate and compare the hematopoietic, anabolic, and endocrine effects of ND and TE in patients with end-stage renal disease. Four of ten patients receiving ND and two of nine patients receiving TE exhibited marked rises (> 1 g/dL) in their hemoglobin concentration, while others showed no significant response. Serum FSH and LH levels were elevated, and serum testosterone levels were reduced during the control periods. They all fell significantly ( p < 0.001) with the administration of ND. Serum FSH and LH levels similarly fell with TE administration, although serum testosterone levels rose (p < 0.001), the latter due to detection of TE on serum testosterone assay. Serum prolactin level was markedly elevated during the control period. It fell during the administration of ND and increased with the use of TE.


2021 ◽  
Vol 44 (4) ◽  
Author(s):  
Wilaiporn Akkabut ◽  
Sutasiny Junhoaton ◽  
Wariya Boonchanta ◽  
Morakot Arbmanee ◽  
Atiporn Ingsathit ◽  
...  

Background: Muscle cramps are a common complication during hemodialysis that can cause patients extremely painful.Objective: To determine factors related to muscle cramps during hemodialysis in patients with end-stage renal disease.Methods: A descriptive correlational study was conducted in end-stage renal disease patients undergoing hemodialysis at Hemodialysis center, Faculty of Medicine Ramathibodi Hospital between February and March 2020. The data collection instruments included muscle cramps report form, demographic questionnaire, and factors related to muscle cramps questionnaire. The data were analyzed using descriptive statistics and multiple logistic regression.Results: A total of 44 patients were recruited in the study. The mean age was 63.3 years. A total of 458 muscle cramps during hemodialysis assessments were recorded in the one month. The result showed that 45 muscle cramps (9.8%) occurred during hemodialysis. Factors significantly related to muscle cramps during hemodialysis included interdialytic weight gain ≥ 3.5 kilograms (OR = 4.5, P < .05), experiencing cramps before hemodialysis (OR = 25.5, P < .05), and high serum bicarbonate concentration (OR = 5.6, P < .05).Conclusions: This study found that 9.8% of patients reported muscle cramps during hemodialysis. Interdialytic weight gain, having cramps before hemodialysis, and serum bicarbonate concentration were significantly related to muscle cramps during hemodialysis in patients with end-stage renal disease.


2005 ◽  
Vol 64 (11) ◽  
pp. 394-395 ◽  
Author(s):  
M. Tanaka ◽  
K. Itoh ◽  
K. Matsushita ◽  
K. Matsushita ◽  
M. Fukagawa

2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Haitham Elbardisi ◽  
Ahmad Majzoub ◽  
Fadwa Al-Ali ◽  
Mohamed Elesnawi ◽  
Abdullah Hamad ◽  
...  

Abstract Background and Aims Male sexual dysfunction is commonly prevalent in patients with end stage renal disease (ESRD) and has been partly attributed to the concurrent state of hyperprolactinemia and hypogonadism, often observed in this patient population. The aim of this study was to evaluate the hormone profile and sexual function of ESRD patient, using validated questionnaires, in attempt to explore this association. Method This was a prospective study which included 98 patients with ESRD who followed in the outpatient department of a tertiary medical centre over a period of 1 year. Patients receiving treatment for hyperprolactinemia or those known to have an endocrine disorder were excluded in addition to patients receiving medical or surgical treatment for erectile dysfunction (ED) or premature ejaculation (PE). After filling the international index for erectile function-5 and the Arabic index for PE questionnaire, morning serum samples were taken from patients to measure testosterone and prolactin levels. Descriptive statistics was used to report frequency or means of variables. Chi-square test was used to examine associations between categorical variables. P&lt;0.05 was considered statistically significant. Results Out of the 98 ESRD patients, 72 (73.6%) were treated with hemodialysis, 13 (13.2%) with peritoneal dialysis and 13 (13.2%) with medical treatment only. Diabetes mellitus was observed in all patients (type 1, 52%; and type 2, 48%), while hypertension, coronary heart disease and dyslipidemia were detected in 97.1%, 34.3% and 25.5%, respectively. The mean age, serum testosterone and prolactin levels were 52.4 ± 12.1 years, 12.95 ± 6.5 nmol/L and 514.2 ± 592.8mIU/L. Results of the PE index questionnaire revealed that 86 (87.7) patients had PE, 9 (9.1%) probable PE and 3 (3.1%) no PE. With IIEF-5, ED was detected in 96 patients; it was severe in 23 (23.5%), moderate- severe ED in 29 (29.4%), mild-moderate ED in 30 (30.4%) and mild in 14 (14.7%). 55 patients had high prolactin while 33 had low testosterone levels. Table 1 presents the IIEF-5 and PE questionnaire results in patients with low/normal testosterone and normal/high prolactin. No significant differences were observed in IIEF or PE levels between patients with low/normal testosterone and normal/high prolactin. Conclusion ESRD is commonly associated with sexual dysfunction that is more likely to be attributed to organic causes rather than solely to endocrine disturbances.


Sign in / Sign up

Export Citation Format

Share Document